Information on Phosphatidylserine (PS) - Benefits, Side effects

Phosphatidylserine is a relatively recently discovered nutrient that is normally produced by the brain. Deficiencies of certain nutrients such as folic acid, vitamin B12 and essential fatty acid, can inhibit its production.

Health Benefits of Phosphatidylserine Supplements - Functions in our body

  • Phosphatidylserine is a vital phospholipid that maintains the integrity of brain cells.
  • Supplementation of phosphatidylserine has been found to improve mental function by increasing the levels of acetylcholine, which transmits brain messages.
  • Studies indicate that depressed older adults taking phosphatidylserine supplements had a positive influence on mood and behavior. It also may taken by younger people struggling with depression.

So, the primary use of phosphatidylserine is in the treatment of memory loss, depression, and behavioural and age-related brain changes in the elderly.

Phosphatidylserine supplements, formulas in combination with other brain-enhancing nutrients, are becoming increasingly popular.
Phosphatidylserine Supplements - buy here

Possible side effects of phosphatidylserine

There are no major side effects of this drug. However,

  • Some participants may develop nausea.
  • Mild insomnia has also been reported to develop.
  • Also, you should avoid phosphatidylserine if you have kidney problems.

Leave your comments

Health News

Surgeon Removes Eight Pound Liver Tumor

The cancerous tumor in Marcus Muhich's liver weighed 8 pounds and was nearly a foot across. Doctors at three major academic medical centers in the Midwest told Muhich his high-grade tumor was inoperable. Then he was referred to Dr... [ read article ]

NIPPV Linked To Increased Hospital Mortality Rates In Small Group Of Patients

Although increased use of noninvasive positive-pressure ventilation (NIPPV) nationwide has helped decrease mortality rates among patients hospitalized with chronic obstructive pulmonary disease (COPD), a small group of... [ read article ]

FDA Approves Label Update For PREZISTA® To Include 192-Week Data In HIV-1-Infected Adult Patients

Starting Treatment Janssen Therapeutics, Division of Janssen Products, LP, announced that the U.S. Food and Drug Administration (FDA) has approved a label update for PREZISTA® (darunavir) tablets to include 192-week data from the ARTEMIS study... [ read article ]

Recommended Stuff

Our Latest Blog Entries...